A pooled analysis of 28 randomized trials of early intravenous β-adrenoceptor blockade after suspected acute myocardial infarction involving 27,536 patients (adapted from ISIS-1 Collaborative Group [50]). Data for in-hospital mortality after early oral β-adrenoceptor blockade in 3611 randomized patients derived from Yusuf et al. [48].